scholarly journals Covid-19 vaccination response in people taking immunosuppressants.

Author(s):  
Igor Brbre
Keyword(s):  

Abstract Covid-19 vaccination response in people taking immunosuppressants, especially Azathioprine.

2019 ◽  
Vol 98 (4) ◽  
pp. 1643-1647 ◽  
Author(s):  
G. Horst ◽  
R. Levine ◽  
R. Chick ◽  
C. Hofacre

2021 ◽  
Author(s):  
Pablo Garcia ◽  
Shuchi Anand ◽  
Jialin Han ◽  
Maria Montez-Rath ◽  
Sumi Sun ◽  
...  

Background Patients on dialysis vaccinated with the attenuated adenovirus SARS-CoV-2 vaccine might mount an impaired response to vaccination. Methods We evaluated the humoral vaccination response among 2,099 fully vaccinated patients receiving dialysis. We used commercially available assays (Siemens) to assess prevalence of no response or diminished response to COVID-19 vaccination by vaccine type. We defined no seroconversion as lack of change from negative to positive in total RBD Ig antibody, no detectable response on semiquantitative RBD IgG antibody (index value <1) as no RBD IgG response, and a semiquantitative RBD IgG index value <10 as diminished RBD IgG response Results Of the 2,099 fully vaccinated patients on dialysis, the proportion receiving the mRNA1273, BNT162b2, and Ad26.COV2.S were 62% (n=1316), 20% (n=416) and 18% (n=367), respectively. A third (33.3%) of patients receiving the attenuated adenovirus Ad26.COV2.S vaccine failed to seroconvert and an additional 36% had no detectable or diminished IgG response even 28-60 days post vaccination. Conclusions One in three fully vaccinated patients receiving dialysis had evidence of an impaired immune response to the attenuated adenovirus Ad26.COV2.S vaccine.


2019 ◽  
Vol 132 ◽  
pp. 16-20 ◽  
Author(s):  
Sandra Andorf ◽  
Sanchita Bhattacharya ◽  
Brice Gaudilliere ◽  
Gary M. Shaw ◽  
David K. Stevenson ◽  
...  

2019 ◽  
Vol 97 (Supplement_3) ◽  
pp. 16-17
Author(s):  
Alexandra Blanchard ◽  
Josselin le Cour Grandmaison ◽  
In Ho Kim ◽  
Yong Min Kim

Abstract Foot and Mouth Disease (FMD) is a severe viral disease with significant economic impact. In endemic countries, livestock may be vaccinated. Standardized capsicum and turmeric oleoresins have demonstrated a boosting effect of vaccination in broiler, but little is known on their efficacy in swine. The objective of this trial was to evaluate the efficiency of these phytomolecules to improve FMD vaccine response in pigs. Cross-breed pigs (n = 120) with body weight of 24.6 kg were allotted into 3 groups of 40 pigs and assigned into 10 replicates from days 70 to 112 of age. Following treatments were applied: NS: no vaccination; FMD-NS: FMD vaccination; FMD-XT: FMD vaccination + supplementation of XT-N (4% capsicum + 4% turmeric oleoresins, Pancosma, Switzerland) at 125 g/ton in feed. The FMD vaccine (Omanisa + O3039 + A22 Iraq-strain, Merial) was injected at day 78. Blood samples were collected at days 88, 93, 98 and 103 to evaluate antibody levels. Growth performance was evaluated at day 112. Data were analyzed using the GLM procedure of SAS®. During the trial, non-vaccinated pigs (NS) did not display antibody titers against FMD, but vaccinated pigs (FMD-NS and FMD-XT) exhibited significant levels of FMD antibodies (P &lt; 0.05). Pigs of FMD-XT group showed significant higher antibody levels at day 93 (P &lt; 0.05), day 98 (P = 0.06) and day 103 (P &lt; 0.05) in comparison to FMD-NS pigs. It indicated significant improvement of FMD vaccine response in comparison to the vaccinated control. At 112 days, FMD-NS pigs were numerically lighter (53.46 kg) in comparison to non-vaccinated pigs (53.89 kg). However, FMD-XT pigs were heavier (54.51 kg) in comparison to NS pigs (+0.62 kg, P &gt;0.05) and FMD-NS pigs (+1.05 kg, P &lt; 0.05). These findings showed that standardized phytomolecules (XT-N) incorporated into pig diet significantly supported FMD vaccination response and alleviated its negative effect on growth.


2012 ◽  
Vol 31 (12) ◽  
pp. 1284-1285 ◽  
Author(s):  
Maaike A. Kusters ◽  
Vinus L.A. Bok ◽  
W.E.A. Bolz ◽  
E.G.W. Huijskens ◽  
M.F. Peeters ◽  
...  

1997 ◽  
Vol 29 (9) ◽  
pp. 1176-1181 ◽  
Author(s):  
HELLE BRUUNSGAARD ◽  
ANDREAS HARTKOPP ◽  
THOMAS MOHR ◽  
HELLE KONRADSEN ◽  
IVER HERON ◽  
...  

Author(s):  
Thomas Perkmann ◽  
Nicole Perkmann-Nagele ◽  
Patrick Mucher ◽  
Astrid Radakovics ◽  
Manuela Repl ◽  
...  
Keyword(s):  

2008 ◽  
Vol 70 (2) ◽  
pp. 147-151 ◽  
Author(s):  
Kate M. Edwards ◽  
Victoria E. Burns ◽  
Alison E. Adkins ◽  
Douglas Carroll ◽  
Mark Drayson ◽  
...  

Vaccine ◽  
2017 ◽  
Vol 35 (37) ◽  
pp. 4886-4895 ◽  
Author(s):  
G.H.J. Wagenvoort ◽  
B.J.M. Vlaminckx ◽  
D.A. van Kessel ◽  
R.C.L. Geever ◽  
B.A.W. de Jong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document